Effect of Trauma and Sepsis on Release of IL-12 p40, p70, and IFN-γ Into Whole Blood
. | Control (n = 12) . | Trauma (n = 17) . | Sepsis (n = 8) . | ||||||
---|---|---|---|---|---|---|---|---|---|
. | LPS . | LPS + rhIFN-γ . | LPS + rhIL-12 p70 . | LPS . | LPS + rhIFN-γ . | LPS + rhIL-12 p70 . | LPS . | LPS + rhIFN-γ . | LPS + rhIL-12 p70 . |
p40 | 964.9 ± 185.8 | 1,673.7 ± 254.54-150 | — | 48.1 ± 7.14-151 | 256.2 ± 58.4*† | — | 61.3 ± 14.54-151 | 161.4 ± 79.54-151 | — |
p70 | 9.0 ± 3.5 | 299.8 ± 105.14-150 | — | ND4-151 | ND4-151 | — | ND4-151 | ND4-151 | — |
IFN-γ | 1,301.8 ± 186.6 | — | 3,223.8 ± 527.84-150 | 320.0 ± 74.74-151 | — | 321.3 ± 98.84-151 | 187.7 ± 45.54-151 | — | 205.2 ± 72.74-151 |
. | Control (n = 12) . | Trauma (n = 17) . | Sepsis (n = 8) . | ||||||
---|---|---|---|---|---|---|---|---|---|
. | LPS . | LPS + rhIFN-γ . | LPS + rhIL-12 p70 . | LPS . | LPS + rhIFN-γ . | LPS + rhIL-12 p70 . | LPS . | LPS + rhIFN-γ . | LPS + rhIL-12 p70 . |
p40 | 964.9 ± 185.8 | 1,673.7 ± 254.54-150 | — | 48.1 ± 7.14-151 | 256.2 ± 58.4*† | — | 61.3 ± 14.54-151 | 161.4 ± 79.54-151 | — |
p70 | 9.0 ± 3.5 | 299.8 ± 105.14-150 | — | ND4-151 | ND4-151 | — | ND4-151 | ND4-151 | — |
IFN-γ | 1,301.8 ± 186.6 | — | 3,223.8 ± 527.84-150 | 320.0 ± 74.74-151 | — | 321.3 ± 98.84-151 | 187.7 ± 45.54-151 | — | 205.2 ± 72.74-151 |
Whole blood obtained from healthy individuals (controls, n = 12) and critically ill patients (n = 25) was incubated with LPS (1 ng/mL) in the presence or absence of either rhIL-12 p70 (5 ng/mL) or rhIFN-γ (10 ng/mL) for 24 hours. The group of critically ill patients was divided according to the origin of the insult (trauma v sepsis). Plasma levels of IL-12 p40 (pg/mL), p70 (pg/mL), and IFN-γ (pg/mL) were measured using specific ELISA. Data are presented as mean ± SEM.
Abbreviation: ND, not detectable.
P < .05 LPS versus LPS + rhIFN-γ/LPS + rhIL-12 p70.
P < .05 patient versus control.